These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9285225)
21. The role of co-stimulation in airway inflammation. Djukanovic R Clin Exp Allergy; 2000 Jun; 30 Suppl 1():46-50. PubMed ID: 10849475 [TBL] [Abstract][Full Text] [Related]
22. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832 [TBL] [Abstract][Full Text] [Related]
23. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428 [TBL] [Abstract][Full Text] [Related]
24. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S Transplant Proc; 1999; 31(1-2):1244. PubMed ID: 10083555 [No Abstract] [Full Text] [Related]
25. Local or short-term systemic costimulatory molecule blockade prolongs rat corneal allograft survival. Thiel MA; Steiger JU; O'Connell PJ; Lehnert AM; Coster DJ; Williams KA Clin Exp Ophthalmol; 2005 Apr; 33(2):176-80. PubMed ID: 15807827 [TBL] [Abstract][Full Text] [Related]
26. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. Steurer W; Nickerson PW; Steele AW; Steiger J; Zheng XX; Strom TB J Immunol; 1995 Aug; 155(3):1165-74. PubMed ID: 7543517 [TBL] [Abstract][Full Text] [Related]
27. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311 [TBL] [Abstract][Full Text] [Related]
28. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Fu F; Li W; Lu L; Fung JJ; Thomson AW; Qian S Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185 [No Abstract] [Full Text] [Related]
29. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996 [TBL] [Abstract][Full Text] [Related]
30. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Hale DA; Gottschalk R; Maki T; Monaco AP Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417 [TBL] [Abstract][Full Text] [Related]